Formulary

Pressed Powder

Released by Kemin Personal Care

May 8, 2013


Phase A
Mica CI 77019 (Presperse)
65.94
Kaolin (Brenntag Specialties)
5.00
Amihope LL (Lauroyl lysine) (Ajinomoto)
3.00
Zinc stearate (Brenntag Specialties)
2.00
Silica (Presperse)
2.00
Titanium dioxide CI 7789 (Brenntag)
8.88
Iron oxides CI 77492 (Sensient)
2.10
Iron oxides CI 77499 (Sensient)
0.34
Iron oxides CI 77491 (Color Techniques)
0.74

Phase B
Lysofix Liquid (Kemin) (Glycerin (and) glycine soja (soybean) seed extract)
3.00
Rosamox (Kemin) (Helianthus annuus (sunflower) seed oil (and) rosmarinus officinalis (rosemary) leaf extract
0.50
LexFeel 350 N (Inolex) (Diheptyl succinate (and) capryloyl glycerin)
3.00
Florasun 90 (Inolex) (Helianthus annuus (sunflower) seed oil)
2.0
Lexgard Natural (Inolex) (Glyceryl caprylate (and) glyceryl undecylenate)
1.50

Procedure
Weigh phase A ingredients. Pulverize phase A until pigments are dispersed. Premix phase B until uniform. Add phase B to phase A and pulverize until uniform. Check for oil spots.

Properties
Appearanceu2014Smooth, silky pressed powder; Coloru2014medium beige; Stabilityu2014stable after 3 months at 40°C and 50°C; loss in moisture should not be more than 1.0% at 40°C and 50°C after 2 months, stable for 5 freeze-thaw cycles, passed drop test, pass puff test.

More Information
Kemin Industries Inc.n(formulated in conjunction with Architectural Beauty),n515-697-4165,nEmail: personalcare@kemin.com,nWebsite: www.kemin.com/personalcare
blog comments powered by Disqus
  • Who Makes That?

    Who Makes That?

    Tom Branna, Editorial Director||April 1, 2016
    From concept and formulation to testing and filling, today’s contract manufacturers perform a range of services for marketers

  • Multi-Cultural Beauty Update

    Multi-Cultural Beauty Update

    Christine Esposito, Associate Editor||April 1, 2016
    Established brands and start-ups address the needs of multi-cultural beauty consumers.

  • The Scalp Microbiome

    The Scalp Microbiome

    Nava Dayan PhD, Dr. Nava Dayan LLC||April 1, 2016
    A review of recent findings and innovative approaches for treating scalp disorders.